R-pharm International, Llc

This study is testing a drug called olokizumab in children and teens (ages 2 to 18) with active juvenile idiopathic arthritis, a type of arthritis. The main goal is to see how the drug moves through the body and to check its safety and effectiveness. About 71 participants will re…